Feasibility study of a smartphone-based online training to manage panic attacks and agoraphobia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004985

Enrollment

Registered

2013-05-22

Start date

2013-05-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F41.0 F40.01

Interventions

Group 1: Arm 1: six-week online training with supporting emails (guided self-help). The total sample (N = 10) gets access to “GET.ON Panik” and the smartphone app “GET.ON PAPP”. Both are components of

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: clinical relevant complaints about panic attacks and agoraphobia (Panic and Agoraphobia Scale 9-28), internet access, availability of a smartphone, valid email address

Exclusion criteria

Exclusion criteria: - suicidality at baseline, measured with item 9 of the BDI II (value > 1) and question A9 of the SCID, section A: affective disorder - current psychotherapeutic treatment or on the waiting list for such a treatment - not willing to sign the consent form

Design outcomes

Primary

Measure	Time frame
Acceptance of the mobile application measured with a questionnaire developed according to the Technology-Acceptance-Model (Davis, Bagozzi, & Warshaw, 1989) after the training (8 weeks). At this stage a semi-structured interview regarding the acceptance of the mobile application will be conducted additionally.	—

Secondary

Measure	Time frame
Panic and agoraphobia symptoms: - measures with Panic and Agoraphobia Scale (P&A), pre and post (8 weeks) - measures with Questionnaire on Body-related Anxiety, Cognitions and Avoidance (AKV), pre and post (8 weeks) - measures with Hamilton Anxiety Scale (HAMA), pre and post (8 weeks); Depressive symptoms: measures with Center for Epidemilogic Studies Depression Scale (CES-D), pre and post (8 weeks); Quality of life: - measures with Short version of Health Survey (SF-12), pre and post (8 weeks) - measures with EuroQuol (EQ-5D), pre and post (8 weeks)	—

Measure

Time frame

Panic and agoraphobia symptoms: - measures with Panic and Agoraphobia Scale (P&A), pre and post (8 weeks) - measures with Questionnaire on Body-related Anxiety, Cognitions and Avoidance (AKV), pre and post (8 weeks) - measures with Hamilton Anxiety Scale (HAMA), pre and post (8 weeks); Depressive symptoms: measures with Center for Epidemilogic Studies Depression Scale (CES-D), pre and post (8 weeks); Quality of life: - measures with Short version of Health Survey (SF-12), pre and post (8 weeks) - measures with EuroQuol (EQ-5D), pre and post (8 weeks)

—

Countries

Germany

Contacts

Public ContactLara Ebenfeld

Leuphana Universität Lüneburg GET.ON Gesundheitstraining.Online / Innovations-Inkubator

ebenfeld@inkubator.leuphana.de04131 677 7874

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026